HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Rating of “Moderate Buy” by Analysts

HealthEquity, Inc. (NASDAQ:HQY) has received an average rating of “Moderate Buy” from the fourteen ratings firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $110.71.

Several analysts have recently weighed in on the stock. JMP Securities raised their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Bank of America upped their target price on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Finally, The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock.

HealthEquity Stock Up 1.1 %

HQY stock opened at $99.74 on Friday. The company’s 50 day moving average is $97.86 and its 200 day moving average is $85.89. The stock has a market cap of $8.64 billion, a price-to-earnings ratio of 91.50, a price-to-earnings-growth ratio of 1.08 and a beta of 0.54. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity has a 1-year low of $65.01 and a 1-year high of $105.82.

Insider Activity

In related news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the transaction, the director now directly owns 66,469 shares in the company, valued at $6,750,591.64. The trade was a 11.04 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Frank Corvino sold 1,039 shares of the stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 34,289 shares of company stock worth $3,355,718. Insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Several large investors have recently modified their holdings of the company. Paladin Wealth LLC bought a new position in HealthEquity in the third quarter worth approximately $39,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of HealthEquity in the 2nd quarter worth $73,000. GAMMA Investing LLC raised its holdings in HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after purchasing an additional 344 shares during the period. Quarry LP lifted its position in HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares in the last quarter. Finally, 1620 Investment Advisors Inc. bought a new stake in HealthEquity during the third quarter valued at about $112,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.